Does physiologic stress and inflammation produce the low T3/high rT3 pattern seen in NTIS?

The physiological response to systemic stress and inflammation significantly alters thyroid hormone metabolism, creating a specific clinical profile known as Non-Thyroidal Illness Syndrome (NTIS) or "low T3 syndrome." This state is characterized by a marked decrease in circulating active triiodothyronine (T3) and a concomitant rise in inactive reverse T3 (rT3), despite a often normal thyroxine (T4) level.

Clinical and Effectiveness Evidence

In clinical settings, particularly among critically ill or highly stressed patients, the degree of T3 suppression and rT3 elevation serves as a powerful prognostic marker.

• Correlative Findings: Research in intensive care units demonstrates that serum T3 levels are inversely correlated with inflammatory markers like Interleukin-6 (IL-6). In sepsis and trauma patients, high rT3 levels and low T3/rT3 ratios are strong predictors of mortality (p < 0.05 in multiple cohorts).
• Patient Demographics: While most heavily studied in acute critical illness, these metabolic shifts are also observed in chronic inflammatory states and significant psychological or physiological stress, though usually to a less extreme degree.

Mechanistic Explanations

The "non-thyroidal illness pattern" is driven by a coordinated shift in the activity of deiodinase enzymes, which regulate the activation and inactivation of thyroid hormones at the tissue level.

• Inhibition of T3 Production: Inflammatory cytokines (TNF-α, IL-6, IL-1β) and cortisol suppress the activity of Type 1 deiodinase (D1) in the liver and kidneys. D1 is responsible for the majority of peripheral T4-to-T3 conversion; its inhibition directly reduces the circulating pool of active T3.
• Upregulation of T3 Inactivation: Simultaneously, stress signals induce the expression of Type 3 deiodinase (D3) in tissues where it is normally absent, such as skeletal muscle and liver. D3 actively converts T4 into rT3 and degrades existing T3 into T2, effectively "shunting" thyroid precursors away from active pathways.
• Intracellular Signaling: These changes are mediated through the NF-κB signaling pathway, which interferes with the transcriptional regulation of deiodinase genes. Furthermore, oxidative stress during illness depletes glutathione, a necessary cofactor for deiodinase function, further impairing enzyme efficiency.

Bottom line

Physiologic stress and inflammatory signaling (via IL-6 and cortisol) cause a rapid shift in deiodinase activity—inhibiting T3-producing D1 and inducing T3-inactivating D3. This results in the characteristic NTIS pattern of low T3 and high rT3, which serves as a conserved adaptive mechanism to conserve energy during metabolic crisis.